New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2013
10:00 EDTABV, DLPH, SRCL, VNR, CVA, TAP, TDY, VR, MPLX, ADT, SBY, IMPV, PKY, CAPOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: ADT Corp. (ADT) initiated with a Buy at Stifel Nicolaus... CAI International (CAP) initiated with an Outperform at William Blair... Imperva (IMPV) initiated with a Market Perform at JMP Securities... MPLX (MPLX) initiated with a Market Perform at Wells Fargo... Parkway Properties (PKY) initiated with a Buy at BofA/Merrill... Silver Bay Realty Trust (SBY) initiated with an Outperform at JMP Securities... Stericycle (SRCL) initiated with an Equal Weight at Barclays... Validus (VR) initiated with an Overweight at Barclays... Covanta (CVA) initiated with an Overweight at JPMorgan... Delphi Automotive (DLPH) initiated with an Outperform at CLSA... Teledyne Technologies (TDY) initiated with a Buy at Needham... Vanguard Natural (VNR) initiated with a Buy at Ladenburg... AB InBev (ABV) initiated with a Buy at ISI Group... Molson Coors (TAP) initiated with a Neutral at ISI Group.
News For ADT;CAP;IMPV;MPLX;PKY;SBY;SRCL;VR;CVA;DLPH;TDY;VNR;ABV;TAP From The Last 14 Days
Check below for free stories on ADT;CAP;IMPV;MPLX;PKY;SBY;SRCL;VR;CVA;DLPH;TDY;VNR;ABV;TAP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 10, 2014
10:00 EDTIMPVImperva falls 40.7%
Subscribe for More Information
09:21 EDTIMPVOn The Fly: Pre-market Movers
Subscribe for More Information
09:00 EDTIMPVImperva falls 34.1%
Subscribe for More Information
08:57 EDTIMPVImperva should be bought after negative preannouncement, says Pacific Crest
After Impreva preannounced lower than expected Q1 revenue, Pacific Crest blamed the miss on a lack of sales execution and lengthening sales cycles. However, the firm is still upbeat on Imperva's outlook, as it expects demand for security products to increase. Pacific Crest reduced its price target on Imperva to $48 from $62. It recommends buying other IT security names, including Palo Alto (PANW) and Proofpoint (PFPT), on weakness in the wake of Imperva's guidance. The firm keeps Outperform ratings on all the stocks named.
08:45 EDTIMPVImperva price target lowered to $43 from $57 at BMO Capital
Subscribe for More Information
08:25 EDTIMPVImperva downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank downgraded Imperva following the negative Q1 pre-announcment.
07:53 EDTIMPVImperva price target lowered to $42 from $62 at JPMorgan
Subscribe for More Information
07:37 EDTIMPVImperva price target lowered to $45 from $57 at Stephens
Stephens lowered its price target on Imperva to $45 after the company's preliminary Q1 results came in below expectations, but the firm believes the Q1 miss was timing related and that Imperva's growth can reaccelerate. The firm maintains its Overweight rating on the stock.
07:15 EDTIMPVImperva downgraded at Oppenheimer
Subscribe for More Information
06:48 EDTTAPMolson Coors downgraded to Neutral from Buy at Nomura
Subscribe for More Information
06:00 EDTIMPVImperva downgraded to Perform from Outperform at Oppenheimer
Subscribe for More Information
April 9, 2014
19:01 EDTIMPVOn The Fly: After Hours Movers
Subscribe for More Information
17:49 EDTIMPVImperva plummets after lowering Q1 EPS and revenue outlook
Subscribe for More Information
17:32 EDTIMPVImperva Q1 miss likely to weigh on Security sector, says Wells Fargo
Wells Fargo believes the magnitude of Imperva's (IMPV) Q1 miss will weigh on the Cyber Security industry since expectations for the group were relatively high going into Q1 earnings. Names in the space include Check Point (CHKP), Fortinet (FTNT), FireEye (FEYE), Palo Alto (PANW) and Symantec (SYMC). Wells notes, however, that it sees little direct fundamental implications for other names in the group as Imperva's issues were likely more company specific. Wells has Outperform ratings on Check Point, FireEye, Palo Alto and Fortinet.
16:17 EDTIMPVImperva plunges after hours following outlook
Shares were last down over 29% in the extended session to $33.50 following a weaker outlook from the company. At that price next support is at $31. Resistance is at $35.25.
16:11 EDTIMPVImperva sinks 30% following lowered Q1 outlook
Subscribe for More Information
16:10 EDTIMPVImperva lowers Q1 adj EPS view to (44c)-(40c) from (37c)-(33c), consensus (35c)
Subscribe for More Information
16:09 EDTIMPVImperva lowers Q1 revenue view to $31M-$31.5M from $36M-$37M
Subscribe for More Information
16:08 EDTIMPVImperva lowers Q1 revenue view
Subscribe for More Information
06:28 EDTADT ADT Corp. May volatility increases to 41 into Q2
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use